Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: A biocompatible nanoformulation of curcumin analogue and curd exosomes targeting EphA2 signalling cascade in head and neck cancer

Fig. 2

A Comparative analysis of the bioaccessibility of curcumin, CAA, and CD EXO + CAA. The statistical analysis was carried out by a one-way ANOVA test with n=3. (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Bars indicate mean ± SEM. B DiO-labelled exosomes interact with HNC cells. C The cell viability of KB-3-1 cells and HEp-2 cells treated with CAA and CD EXO + CAA was detected by MTT assay for 48 h. Graphs represent the mean ±SEM for the cell viability experiment

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us